PainReform ( (PRFX) ) has shared an update.
On April 3, 2025, PainReform Ltd. held an Extraordinary General Meeting of Shareholders, which was adjourned due to a lack of quorum. The meeting is rescheduled for April 10, 2025, at the same location. This delay may impact the company’s decision-making processes and timelines for any resolutions that require shareholder approval.
More about PainReform
PainReform Ltd. operates within the pharmaceutical industry, focusing on the development and commercialization of reformulated pain relief products. The company is based in Tel Aviv, Israel, and aims to enhance the efficacy and safety of existing pain medications.
YTD Price Performance: -29.01%
Average Trading Volume: 1,130,128
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.82M
Learn more about PRFX stock on TipRanks’ Stock Analysis page.